Connect with us

Business

WestJet cancels Boeing 737 MAX flight moments before takeoff | Venture – Daily Hive

Published

 on


WestJet cancelled a Boeing 737 MAX flight after it had already left its gate at Calgary International Airport on January 22.

A spokesperson for the airline confirmed to Daily Hive that WestJet flight WS658, which was supposed to travel to Toronto, had to return to its gate after push off on Friday morning.

“After a normal engine start, a standard function of the health monitoring system indicated a potential fault that needed to be verified and reset,” said Lauren Stewart, a media relations manager at WestJet.

“This process takes time and requires a subsequent engine run, which we do not perform with guests on board.”

The flight, as well as its Toronto to Calgary return, were cancelled in the interest of passenger’s time. Guests were rebooked on the next available flight.

Stewart stressed that the decision to cancel the flight was only made because there was space on a Toronto-bound Dreamliner flight.

Had passengers not already been on their way, the WS658 flight would have operated as normal following the all-clear by a maintenance team, she said. The plane has since been inspected and will return to operation on January 24.

“There was no safety risk to our guests and this was unrelated to any previous matter,” Stewart said.

In March 2019, Transport Canada grounded Boeing 737 MAX planes across the country following a pair of deadly crashes that killed 346 people.

The aircraft’s return-to-service was approved on January 18, 2021. WestJet began flying the planes on January 21, the first airline in Canada to do so in nearly two years.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Nokia stock jumps following rally in Reddit favorites – MarketWatch

Published

 on


Nokia stock jumped in early trading on Thursday, following a rally in Reddit favorites GameStop and AMC Entertainment. 

The Finnish telecom equipment maker has become a favorite among Reddit’s WallStreetBets forum in recent weeks. The latest price move comes after videogames retailer GameStop
GME,
+103.94%

and movie-theater chain AMC Entertainment
AMC,
+18.05%

— also popular with retail investors — soared on Wednesday. GameStop shares were 57% higher in premarket trading, while AMC stock was 17% up, suggesting the rally is set to continue.

Nokia’s Finnish-listed shares
NOKIA,
+7.73%

climbed close to 7% in morning trading — one of the sharpest risers on the pan-European Stoxx 600 index — while the ADRs
NOK,
+2.28%

were 6.2% higher in premarket trading.

The company’s popularity with retail investors has sent the stock on something on a roller-coaster ride so far this year. After surging 55% in the space of three days at the end of January, the company felt the need to release a statement saying it couldn’t explain the rally.

The shares have since retreated but the Finnish stock remains 11% up year-to-date, while the ADRs were 3.3% as of Wednesday’s close.

GameStop shares more than doubled late on Wednesday, with trading being twice ahead of the closing bell. The stock had opened lower after the retail chain announced the sudden departure of its financial chief on Tuesday, before soaring late in the day. AMC Entertainment gained 18.1%.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Is a single COVID-19 vaccine dose enough for those previously infected? – Global News

Published

 on


As coronavirus vaccines continue to roll out to vulnerable populations across Canada, health officials are looking at data about the effectiveness of a single dose in preventing COVID-19 illness.

A new letter by two Canadian experts published in the New England Journal of Medicine (NEJM) last week stated that with a 92.6 per cent efficacy, the first dose of the Pfizer vaccine was “highly protective.”

Read more:
Delaying second dose of coronavirus vaccines is ‘risky gamble,’ experts say

During a news conference on Feb. 18, Dr. Howard Njoo, Canada’s deputy chief public health officer, said that according to early data, the indicators are that there is a “good level of protection” after just one dose.


Click to play video 'How COVID-19 vaccination plans are evolving in Quebec, Ontario'



2:47
How COVID-19 vaccination plans are evolving in Quebec, Ontario


How COVID-19 vaccination plans are evolving in Quebec, Ontario

France’s health authority, H.A.S., has gone one step further in recommending that everyone who has been previously infected with COVID-19 receive a single shot, instead of the two-dose regimen prescribed by vaccine makers Pfizer and Moderna.

Story continues below advertisement

The recommendation made on Feb. 12 says the single booster shot should be given three to six months after COVID-19 infection.

The reasoning, according to H.A.S., is that people who have had a confirmed infection should be considered protected for at least three months by post-infection immunity, whether the disease was symptomatic or not.

“It is an interesting approach to take,” said Rowland Kao, professor of veterinary epidemiology and data science at the University of Edinburgh in Scotland.

“And you would expect that natural immunity will give you .. a more broad response (than the first dose) because it is the original virus that is causing it.”


Click to play video 'Pfizer-BioNTech COVID-19 vaccine 80-90% effective after 1st dose'



2:29
Pfizer-BioNTech COVID-19 vaccine 80-90% effective after 1st dose


Pfizer-BioNTech COVID-19 vaccine 80-90% effective after 1st dose

A spokesperson for H.A.S. told Global News that the French health minister has yet to make a decision on the recommendation. For now, France is giving two shots for both the Pfizer and Moderna vaccine.

Story continues below advertisement

Amid shortages in vaccine supplies and a rush to control the pandemic, some experts say this strategy is worth considering as it could potentially save precious doses.

Read more:
Johnson & Johnson one-shot vaccine is safe, prevents COVID-19, U.S. FDA says

Dr. Gerald Evans, chair of infectious diseases at Queen’s University in Kingston, Ont., said a single dose of vaccine in someone previously infected is “reasonable while we continue to have a short supply of vaccine globally.”

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Two small studies in the United States by Mount Sinai and the University of Maryland showed a single dose in people who had COVID-19 provided at least the same amount of protection as two shots in people who haven’t been infected. The data has not yet been peer-reviewed.

You could treat getting COVID-19 as like getting your first dose of vaccine,” said Dr. Zain Chagla, an infectious diseases physician at St. Joseph’s Healthcare in Hamilton.

A single dose could serve as a booster to get the “prime long-term response,” he told Global News.

“You could definitely save on vaccine supply with these mRNA vaccines by only giving those individuals a single dose moving forward.”

Some Canadian provinces have decided to delay giving the second dose, which some experts have called a “risky approach” and “a gamble.”

Story continues below advertisement

Last week, New Brunswick health officials said the province will delay the second dose of the Pfizer-BioNTech vaccine for those who are considered to be at a lower risk.

In mid-January, Quebec announced that it was pushing the time between the two doses to a maximum of three months in an attempt to vaccinate more seniors faster with a first injection.

Vaccine manufacturers Pfizer and Moderna propose intervals of 21 and 28 days, respectively.


Click to play video 'Why is Health Canada taking so long to approve the AstraZeneca vaccine?'



1:55
Why is Health Canada taking so long to approve the AstraZeneca vaccine?


Why is Health Canada taking so long to approve the AstraZeneca vaccine?

In its recommendation for the previously infected, France’s H.A.S. says people who have proven immunosuppression, which makes them more vulnerable to severe COVID-19 illness, should be given the two doses.

It also says people who catch the virus in the days after a first dose is given should not receive a second shot within the usual timeframe, but within three to six months after infection.

Story continues below advertisement

Read more:
Booster shots, new clinical trials — What the COVID-19 variants could mean for vaccines

According to the data from the clinical trials, Pfizer’s vaccine, which is 95 per cent effective, can offer partial protection as early as 12 days after the first dose.

Kao said the immediate protection after the first dose and second dose is quite similar.

However, it still remains to be seen what the long-term immune response will be after the first dose.

We really don’t know how long that protection is going to last,“ said Kao.

The second dose is really there to give you that long-lasting immunity.”


Click to play video 'Quebec public health experts support delaying second COVID-19 dose'



2:00
Quebec public health experts support delaying second COVID-19 dose


Quebec public health experts support delaying second COVID-19 dose

Data analysis by Canadian experts published in the NEJM found a 68.5 per cent vaccine efficacy beginning seven days after Pfizer’s first dose and a 92.6 percent efficacy two weeks after a single shot.

Story continues below advertisement

Based on the evidence so far, Chagla says it is premature to roll out the single-dose strategy on a wide scale and that more research was needed on that front.

“If you could prove that works, you really do save a significant amount of vaccine … and you really can change your vaccine strategy almost overnight if you can implement something like that.”

— With files from Global News’ Linda Boyle

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

OPEC Considers Production Increase At March Meeting – OilPrice.com

Published

 on



OPEC+ Considers Production Increase At March Meeting | OilPrice.com


Julianne Geiger

Julianne Geiger

Julianne Geiger is a veteran editor, writer and researcher for Oilprice.com, and a member of the Creative Professionals Networking Group.

More Info

Related News

OPEC flag

OPEC+ will discuss the possibility of increasing its oil production levels at the next meeting, OPEC+ sources told Reuters on Wednesday.

The group is set to meet on March 4, where it will discuss raising output as much as a half a million barrels per day starting in April, the sources said.

OPEC+ members are currently suppressing oil production by more than 7 million barrels per day, but with oil prices now on the rise and the markets getting the idea that the market could be tightening, OPEC+ may consider loosening the reins.

The last Joint Ministerial Monitoring Committee Meeting of OPEC+ met in the first week of February ended without many surprises. For the month of February, another 75,000 bpd was added to the quotas—65,000 bpd to Russia and 10,000 bpd to Kazakhstan. For the month of March, production quotas were eased again by another 75,000 bpd—again to Russia (65,000 bpd) and Kazakhstan (10,000 bpd).

But Saudi Arabia had announced in January that in February and March, it would voluntarily cut an additional 1 million bpd from its quota.

Saudi Arabia has not committed to cutting this additional million barrels beyond March, so it’s very possible that this OPEC+ meeting will end with an additional 1.5 million barrels added into the mix: an additional 500,000 bpd added to the production quotas, and an additional million bpd from Saudi Arabia.

The oil markets have improved in recent weeks, with crude oil inventories in the world’s most visible oil market, the United States, finally returning to its five-year average. The price of Brent oil has rebounded to more than $67 per barrel, with WTI traded above $63 as of Wednesday afternoon. This is the highest level oil prices have seen in over a year.

By Julianne Geiger for Oilprice.com

More Top Reads From Oilprice.com:

Join the discussion | Back to homepage



Related posts

Let’s block ads! (Why?)



Source link

Continue Reading

Trending